Scientists reveal how ER+ breast cancer uses cholesterol-based molecule to evade anti
New research funded by Breast Cancer Now has identified how the most common breast cancers could be using a cholesterol-based molecule to evade standard anti-hormone treatments, causing patients’ disease to return.